Asia
The 3-year project aims to lower the cost of manufacturing mAbs significantly - to $5/g.
Shares of Teva are up more than 5 percent this morning after Israeli media reported billionaire businessman Len Blavatnik is considering taking a large stock position in the pharma giant.
Fosun Pharma will pay up to $98M to buy the 69% of Henlix Biotech it doesn’t already own.
Annoroad raised $100M in a Series C financing, led by SAIF Partners and joined by SBCVC, Shenzhen GTJA Investment Group and Ping An Ventures.
EyeOP1 is an high-intensity focused ultrasound device that is the first non-invasive treatment for glaucoma in China.
The acquisition is expected to close by the end of 2017.
The company plans to invest nearly $10 million over five years to establish operations in Indiana.
Maxhealth Medicine of Wuxi, China struck a deal with Switzerland’s Legacy Healthcare to commercialize Legacy’s CG 210 in Mainland China and Macao.
China Resources Pharma announced plans to raise $368.5 million for a China life science investment fund.
Amgen and Kirin have decided to dissolve their joint venture, Kirin-Amgen.
PRESS RELEASES